The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
The Relationship Between Cyclooxygenase-2 Expression and Colorectal Cancer
Abstract
CONTEXT: Epidemiological studies have implicated the inducible form of cyclooxygenase (COX-2) in the pathogenesis of colorectal cancer; however, its role is not fully understood. OBJECTIVE: To examine the relationship between the expression of COX-2 in human colorectal cancer and patient survival. DESIGN: Patients diagnosed as having colorectal cancer were evaluated and followed up for up to 9.4 years (median follow-up, 2.7 years). Tumor sections were stained for COX-2 using a rabbit polyclonal antibody raised against human COX-2. The extent of COX-2 staining was graded by 2 observers blinded to outcome. Preabsorption of the anti-COX-2 antibody with a COX-2 peptide abolished the staining, demonstrating the specificity of the assay. SETTING: Gastrointestinal unit of a large general teaching hospital in Dublin, Ireland. PARTICIPANTS: Seventy-six patients (median age, 66.5 years) with colorectal cancer (Dukes tumor stage A, n = 9; Dukes B, n = 30; Dukes C, n = 25; Dukes D, n = 12) whose diagnosis was made between 1988 and 1991. Fourteen normal colon biopsies were stained for COX-2 as controls. MAIN OUTCOME MEASURES: Survival in years following diagnosis compared by extent of COX-2 epithelial staining (grade 1, <1%; grade 2, 1%-19%; grade 3, 20%-49%; grade 4, > or = 50%), Dukes stage, tumor size, and lymph mode metastasis. RESULTS: COX-2 was found in tumor epithelial cells, inflammatory cells, vascular endothelium, and/or fibroblasts. The extent of epithelial staining was heterogeneous, varying markedly among different tumors. Normal tissue adjacent to the tumors also stained weakly for COX-2. No COX-2 was detected in control tissue samples. The Kaplan-Meier survival estimate was 68% in patients who had grade 1 tumor epithelial staining compared with 35% in those with higher grades combined (log-rank chi2 = 5.7; P = .02). Greater expression of COX-2 correlated with more advanced Dukes stage (Kendall tau-b, 0.22; P = .03) and larger tumor size (Kendall tau-b, 0.21; P = .02) and was particularly evident in tumors with lymph node involvement (Kendall tau-b, 0.26; P = .02). CONCLUSIONS: Our data indicate that COX-2 expression in colorectal cancer may be related to survival. These data add to the growing epidemiological and experimental evidence that COX-2 may play a role in colorectal tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F., & Taketo, M. M. (1996) · Cell · doi:10.1016/s0092-8674(00)81988-1 · Cited by 2,366
Cyclooxygenase regulates angiogenesis induced by colon cancer cells
Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., & DuBois, R. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81433-6 · Cited by 2,272
Treatment of Colonic and Rectal Adenomas with Sulindac in Familial Adenomatous Polyposis
Giardiello, F. M., Hamilton, S. R., Krush, A. J., Piantadosi, S., Hylind, L. M., Celano, P., Booker, S. V., Robinson, C. R., & Offerhaus, G. J. A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305063281805 · Cited by 1,717
Aspirin Use and Reduced Risk of Fatal Colon Cancer
Thun, M. J., Namboodiri, M. M., & Heath, C. W. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112053252301 · Cited by 1,673
The classification of cancer of the rectum
Dukes, C. E. (1932) · The Journal of Pathology and Bacteriology · doi:10.1002/path.1700350303 · Cited by 1,505
Hla, T., & Neilson, K. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7384 · Cited by 1,465
Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential
Tsujii, M., Kawano, S., & DuBois, R. N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3336 · Cited by 1,398
Expression of cyclooxygenase-1 and -2 in human colorectal cancer.
Sano, H., Kawahito, Y., Wilder, R. L., Hashiramoto, A., Mukai, S., Asai, K., Kimura, S., Kato, H., Kondo, M., & Hla, T. (1995) · PubMed · Cited by 1,126
Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer.
Kargman, S., O’Neill, G. P., Vickers, P. J., Evans, J. F., Mancini, J. A., & Jothy, S. (1995) · PubMed · Cited by 824
Jones, D. A., Carlton, D. P., McIntyre, T. M., Zimmerman, G. A., & Prescott, S. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52976-8 · Cited by 708
Aspirin and the potential role of prostaglandins in colon cancer.
Marnett, L. J. (1992) · PubMed · Cited by 678
Kune, G. A., Kune, S., & Watson, L. F. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dym193 · Cited by 654
Altered eicosanoid levels in human colon cancer.
Rigas, B., Goldman, I. S., & Levine, L. (1993) · PubMed · Cited by 569
Shiff, S. J., Qiao, L., Tsai, L. L., & Rigas, B. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118060 · Cited by 404
Jacoby, R. F., Marshall, D. J., Newton, M. A., et al. (1996) · PubMed · Cited by 295
Reduced Risk of Large-Bowel Adenomas Among Aspirin Users
Greenberg, E. R., Baron, J. A., D. H., F., Mandel, J. S., & Haile, R. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.11.912 · Cited by 293
Crohn's-like lymphoid reaction and colorectal carcinoma: a potential histologic prognosticator.
Graham, D. M., & Appelman, H. D. (1990) · PubMed · Cited by 283
The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis
Pasricha, P. J., Bedi, A., O'Connor, K., Rashid, A., Akhtar, A. J., Zahurak, M. L., Piantadosi, S., Hamilton, S. R., & Giardiello, F. M. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90411-5 · Cited by 251
Aspirin use and potential mechanisms for colorectal cancer prevention.
Williams, C. S., Smalley, W., & DuBois, R. N. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119651 · Cited by 244
Incidence of colorectal carcinoma in the U.S.
Troisi, R. J., Freedman, A. N., & Devesa, S. S. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990415)85:8<1670::aid-cncr5>3.0.co;2-m · Cited by 203
Barnes, C. J., & Lee, M. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70305-1 · Cited by 153
DuBois, R. N., Tsujii, M., Bishop, P. R., Awad, J. A., Makita, K., & Lanahan, A. A. (1994) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1994.266.5.g822 · Cited by 149
A protective effect of sulindac against chemically‐induced primary colonic tumours in mice
Moorghen, M., Ince, P. G., Finney, K. J., et al. (1988) · The Journal of Pathology · doi:10.1002/path.1711560411 · Cited by 137
Aspirin Use and Reduced Risk of Fatal Colon Cancer
Travers, J. D., Temple, A. R., & Gates, T. N. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205073261912 · Cited by 131
Yang, V. W., Shields, J. M., Hamilton, S. R., Spannhake, E. W., Hubbard, W. C., Hylind, L. M., Robinson, C., & Giardiello, F. M. (1998) · PubMed · Cited by 129
Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells
Tsujii, M., Kawano, S., Tsuji, S., Sawaoko, H., Hori, M., & DuBois, R. N. (1998) · Cell · doi:10.1016/s0092-8674(02)09420-5 · Cited by 123
Aspirin and nonsteroidal anti-inflammatory agents and risk for colorectal adenomas
Sandler, R. S., Galanko, J. C., Murray, S. C., Helm, J. F., & Woosley, J. T. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70526-8 · Cited by 122
Jass, J. R., & Morson, B. C. (1987) · Journal of Clinical Pathology · doi:10.1136/jcp.40.9.1016 · Cited by 95
Identifying Stage B colorectal cancer patients at high risk of tumor recurrence and death
Mulcahy, H. E., Toner, M. E., Patchett, S. E., Daly, L., & O’Donoghue, D. P. (1997) · Diseases of the Colon & Rectum · doi:10.1007/bf02050424 · Cited by 84
Influence of various prostaglandin synthesis inhibitors on DMH-induced rat colon cancer
Metzger, U. F., Meier, J., Uhlschmid, G. K., & Wei-he, H. (1984) · Diseases of the Colon & Rectum · doi:10.1007/bf02553001 · Cited by 76
Skelly, M. M., Troy, A., Duffy, M. J., Mulcahy, H. E., Duggan, C., Connell, T. G., O’Donoghue, D. P., & Sheahan, K. D. (1997) · PubMed · Cited by 55
A Mini-Workshop to Train Medical Students to Use a Patient-Centered Approach to Smoking Cessation
ALLEN, S. S., Bland, C. J., & Dawson, S. J. (1990) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(18)31041-9 · Cited by 32
Cited by
Terzić, J., Grivennikov, S., Karin, E., & Karin, M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.058 · Cited by 1,974
Thun, M. J., Henley, S. J., & Patrono, C. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.4.252 · Cited by 1,433
Greenhough, A., Smartt, H. J. M., Moore, A. E., Roberts, H. R., Williams, A. C., Paraskeva, C., & Kaidi, A. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp014 · Cited by 1,220
“A large body of evidence now indicates that elevated levels of COX-2 are present in the majority of colorectal carcinomas [24-28] and in a subset of adenomas [24,25].”
BackgroundHost cyclooxygenase-2 modulates carcinoma growth
Williams, C. S., Tsujii, M., Reese, J., Dey, S. K., & DuBois, R. N. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9621 · Cited by 673
Aspirin Use and Survival After Diagnosis of Colorectal Cancer
Chan, A. T. (2009) · JAMA · doi:10.1001/jama.2009.1112 · Cited by 557
Metadata
- Authors
- Sheehan, K. M.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 1999-10-06
- Volume
- 282
- Issue
- 13
- Pages
- 1254
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2081761148
- Cited by
- 461
- References
- 32
- FWCI
- 14.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.